Your browser doesn't support javascript.
loading
Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China.
Huang, Rui; Fan, Jian-Gao; Shi, Jun-Ping; Mao, Yi-Min; Wang, Bing-Yuan; Zhao, Jing-Min; Lu, Lun-Gen; Zhong, Bi-Hui; Zou, Zheng-Sheng; Xu, You-Qing; Ye, Yi-Nong; Liu, Long-Gen; Lin, Lian-Jie; Rao, Hui-Ying; Wei, Lai.
Afiliação
  • Huang R; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, Peking University People's Hospital, Peking University Hepatology Institute, No.11 Xizhimen South Street, Beijing, 100044, China.
  • Fan JG; Department of Digestive, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shi JP; Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
  • Mao YM; Department of Digestive, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang BY; Department of Digestive, The First Hospital of China Medical University, Shenyang, China.
  • Zhao JM; Department of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Lu LG; Department of Digestive, The First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhong BH; Department of Digestive, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Zou ZS; Department of Pathology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Xu YQ; Department of Digestive, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Ye YN; Department of Infectious Disease, The First Hospital of Fushan, Fushan, China.
  • Liu LG; Department of Hepatology, The Third People's Hospital, Changzhou, China.
  • Lin LJ; Department of Digestive, Shengjing Hospital of China Medical University, Shenyang, China.
  • Rao HY; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, Peking University People's Hospital, Peking University Hepatology Institute, No.11 Xizhimen South Street, Beijing, 100044, China. raohuiyi
  • Wei L; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, No.168, Litang Road, Changping District, Beijing, 102218, China. weilai@mail.tsinghua.edu.cn.
Qual Life Res ; 32(3): 915-922, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36692593
ABSTRACT

PURPOSE:

The Chronic Liver Disease Questionnaire (CLDQ)-Nonalcoholic Fatty Liver Disease (NAFLD) is a disease-specific instrument to assess the health-related quality of life (HRQL) of patients with NAFLD. In order to provide further evidence for the cross-cultural utility of this instrument in the Chinese population, we translated the CLDQ-NAFLD into Chinese and examined its reliability and validity.

METHODS:

Patients with NAFLD in 90 hospitals across China were enrolled in this multicenter cross-sectional survey. Eligible patients completed the Chinese version of CLDQ-NAFLD at enrollment to assess HRQL. Internal consistency of the questionnaire was assessed using Cronbach's alpha coefficient and split-half reliability. Convergent and discriminant validity were assessed using Spearman correlation coefficient. Factor analysis was used to test the construct validity.

RESULTS:

Between March and August 2019, 5181 patients with a mean age of 43.8 ± 13.3 years were enrolled. All domains exhibited good internal consistency, with Cronbach's alpha and split-half reliability greater than 0.70. The scaling success rate of all domains was 100% for convergent validity and 99.4% (179/180) for discriminant validity. The inter-scale correlations indicated a significant correlation between all CLDQ-NAFLD domains (r = 0.608 to 0.832, all p < 0.001). Factor analysis of 36 items extracted 6 factors, which explained 69.14% of the total variance.

CONCLUSION:

The Chinese version of CLDQ-NAFLD is a reliable and valid instrument for assessing the HRQL of Chinese patients with NAFLD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
...